Literature DB >> 27138970

10-year trajectories of depressive symptoms and risk of dementia: a population-based study.

Saira Saeed Mirza1, Frank J Wolters2, Sonja A Swanson1, Peter J Koudstaal3, Albert Hofman1, Henning Tiemeier4, M Arfan Ikram5.   

Abstract

BACKGROUND: Late-life depressive symptoms have been extensively studied for their relationship with incident dementia, but have been typically assessed at a single timepoint. Such an approach neglects the course of depression, which, given its remitting and relapsing nature, might provide further insights into the complex association of depression with dementia. We therefore repeatedly measured depressive symptoms in a population of adults over a decade to study the subsequent risk of dementia.
METHODS: Our study was embedded in the Rotterdam Study, a population-based study of adults aged 55 years or older in Rotterdam (Netherlands), ongoing since 1990. The cohort is monitored continuously for major events by data linkage between the study database and general practitioners. We examined a cohort of participants who were free from dementia, but had data for depressive symptoms from at least one examination round in 1993-95, 1997-99, or 2002-04. We assessed depressive symptoms with the validated Dutch version of the Center for Epidemiology Depression Scale (CES-D) and the Hospital Anxiety and Depression Scale-Depression. We used these data to identify 11-year trajectories of depressive symptoms by latent class trajectory modelling. We screened participants for dementia at each examination round and followed up participants for 10 years for incident dementia by latent trajectory from the third examination round to 2014. We calculated hazard ratios (HR) for dementia by assigned trajectory using two Cox proportional hazards models (model 1 adjusted for age and sex only, and model 2 adjusted additionally for APOEɛ4 carrier status, educational level, body-mass index, smoking, alcohol consumption, cognitive score, use of antidepressants, and prevalent disease status at baseline). We repeated the analyses censoring for incident stroke, restricting to Alzheimer's disease as an outcome, and accounting for mortality as a competing risk for dementia.
FINDINGS: From 1993-2004, we obtained data for depressive symptoms from at least one examination round for 3325 participants (median age: 74·88 years [IQR 70·62-80·06], 1995 [60%] women). We identified five trajectories of depressive symptoms in these 3325 individuals, characterised by maintained low CES-D scores (low; 2441 [73%]); moderately high starting scores but then remitting (decreasing; 369 [11%]); low starting scores, increasing, then remitting (remitting; 170 [5%]); low starting scores that steadily increased (increasing; 255 [8%]); and maintained high scores (high; 90 [3%]). During 26 330 person-years, 434 participants developed incident dementia. Only the trajectory with increasing depressive symptoms was associated with a higher risk of dementia compared with the low depressive symptom trajectory, using model 2 (HR 1·42, 95% CI 1·05-1·94; p=0·024). Additionally, only the increasing trajectory was associated with a higher risk of dementia compared with the low trajectory after censoring for incident stroke (1·58, 1·15-2·16; p=0·0041), restricting to Alzheimer's disease as an outcome (1·44, 1·03-2·02; p=0·034), and accounting for mortality as a competing risk (1·45, 1·06-1·97; p=0·019).
INTERPRETATION: Risk of dementia differed with different courses of depression, which could not be captured by a single assessment of depressive symptoms. The higher risk of dementia only in the increasing trajectory suggests depression might be a prodrome of dementia. FUNDING: Erasmus Medical Center; ZonMw; the Netherlands Ministry of Education Culture and Science; and the Netherlands Ministry for Health, Welfare and Sports.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27138970     DOI: 10.1016/S2215-0366(16)00097-3

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  53 in total

1.  Effects of L-DOPA Monotherapy on Psychomotor Speed and [11C]Raclopride Binding in High-Risk Older Adults With Depression.

Authors:  Bret R Rutherford; Mark Slifstein; Chen Chen; Anissa Abi-Dargham; Patrick J Brown; Melanie W Wall; Nora Vanegas-Arroyave; Yaakov Stern; Veronika Bailey; Emily Valente; Steven P Roose
Journal:  Biol Psychiatry       Date:  2019-04-15       Impact factor: 13.382

2.  Frontal-executive and corticolimbic structural brain circuitry in older people with remitted depression, mild cognitive impairment, Alzheimer's dementia, and normal cognition.

Authors:  Benoit H Mulsant; Aristotle N Voineskos; Neda Rashidi-Ranjbar; Tarek K Rajji; Sanjeev Kumar; Nathan Herrmann; Linda Mah; Alastair J Flint; Corinne E Fischer; Meryl A Butters; Bruce G Pollock; Erin W Dickie; John A E Anderson
Journal:  Neuropsychopharmacology       Date:  2020-05-18       Impact factor: 7.853

3.  Major depression in primary care: making the diagnosis.

Authors:  Chung Wai Mark Ng; Choon How How; Yin Ping Ng
Journal:  Singapore Med J       Date:  2016-11       Impact factor: 1.858

4.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

Review 5.  Could α-Klotho Unlock the Key Between Depression and Dementia in the Elderly: from Animal to Human Studies.

Authors:  Xiang Gao; Yuhong Li; Zuoli Sun; Hong Xu; Guangwei Ma; Qi Deng; Claire X Zhang; Rena Li
Journal:  Mol Neurobiol       Date:  2021-02-01       Impact factor: 5.590

6.  Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.

Authors:  Isabelle Bos; Stephanie J B Vos; Suzanne E Schindler; Jason Hassenstab; Chengjie Xiong; Elizabeth Grant; Frans Verhey; John C Morris; Pieter Jelle Visser; Anne M Fagan
Journal:  Alzheimers Dement       Date:  2019-08-01       Impact factor: 21.566

Review 7.  Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic Implications.

Authors:  Rita Khoury; George T Grossberg
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

8.  Apathy and risk of probable incident dementia among community-dwelling older adults.

Authors:  Meredith A Bock; Amber Bahorik; Willa D Brenowitz; Kristine Yaffe
Journal:  Neurology       Date:  2020-10-14       Impact factor: 9.910

9.  Association of trajectories of depressive symptoms with vascular risk, cognitive function and adverse brain outcomes: The Whitehall II MRI sub-study.

Authors:  Naiara Demnitz; Melis Anatürk; Charlotte L Allan; Nicola Filippini; Ludovica Griffanti; Clare E Mackay; Abda Mahmood; Claire E Sexton; Sana Suri; Anya G Topiwala; Enikő Zsoldos; Mika Kivimäki; Archana Singh-Manoux; Klaus P Ebmeier
Journal:  J Psychiatr Res       Date:  2020-09-09       Impact factor: 4.791

10.  Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study.

Authors:  Archana Singh-Manoux; Aline Dugravot; Agnes Fournier; Jessica Abell; Klaus Ebmeier; Mika Kivimäki; Séverine Sabia
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.